Robert Ford

Track

Insider profile

Currently holds a position at Abbott Laboratories

Performance

Overall performance
2.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 52% 68% 82%
Transactions
7 14% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 9%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
President, Chief Executive Officer, Chief Operating Officer, Director Abbott Laboratories March 31, 2020 -
President, Chief Operating Officer Abbott Laboratories Oct. 15, 2018 - March 31, 2020
Executive Vice President - Medical Devices Abbott Laboratories Jan. 1, 2015 - Oct. 15, 2018
Senior Vice President - Diabetes Care. Abbott Laboratories Jan. 1, 2014 - Jan. 1, 2015
Robert Ford's trades of Abbott Laboratories's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
353.99
Quantity 60,832 +1.2%
Value US$2,093,255
Transaction date
Sale
Price
120.36
Quantity 58,676 -24.7%
Value US$4,998,161
Transaction date
Proposed sale
Price
246.09
Quantity 52,915
Value US$2,615,067
Transaction date
Purchase
Price
107.13
Quantity 18,800 +9.5%
Value US$2,013,967
Transaction date
Sale
Price
131.17
Quantity 285,388 -56.5%
Value US$37,435,200
Transaction date
Proposed sale
Price
131.17
Quantity 285,388
Value US$37,435,238
Transaction date
Sale
Price
116.90
Quantity 61,380 -21.8%
Value US$7,175,322
Transaction date
Sale
Price
116.04
Quantity 80,299 -22.2%
Value US$9,317,896
Transaction date
Proposed sale
Price
116.41
Quantity 141,679
Value US$16,492,852
Transaction date
Sale
Price
105.10
Quantity 102,425 -41.9%
Value US$10,765,154
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-27 2026-08-25
S Sale
60,832 +1.2%
353.99
US$2,093,255 		60,832 +1.2% 353.99 US$2,093,255
2026-08-27 2026-08-25
S Sale
58,676 -24.7%
120.36
US$4,998,161 		58,676 -24.7% 120.36 US$4,998,161
2026-08-25 2026-08-25
PrS Proposed sale
52,915
246.09
US$2,615,067 		52,915 246.09 US$2,615,067
2026-01-26 2026-01-23
B Purchase
18,800 +9.5%
107.13
US$2,013,967 		18,800 +9.5% 107.13 US$2,013,967
2025-02-07 2025-02-05
S Sale
285,388 -56.5%
131.17
US$37,435,200 		285,388 -56.5% 131.17 US$37,435,200
2025-02-05 2025-02-05
PrS Proposed sale
285,388
131.17
US$37,435,238 		285,388 131.17 US$37,435,238
2024-09-13 2024-09-12
S Sale
61,380 -21.8%
116.90
US$7,175,322 		61,380 -21.8% 116.90 US$7,175,322
2024-09-13 2024-09-12
S Sale
80,299 -22.2%
116.04
US$9,317,896 		80,299 -22.2% 116.04 US$9,317,896
2024-09-12 2024-09-12
PrS Proposed sale
141,679
116.41
US$16,492,852 		141,679 116.41 US$16,492,852
2022-08-26 2022-08-25
S Sale
102,425 -41.9%
105.10
US$10,765,154 		102,425 -41.9% 105.10 US$10,765,154